Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD
Clinical trial NCT05165394 · COMPLETED
Trial details
- NCT number
- NCT05165394
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2023-07-07
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.